BioSpace News Archive

Business

REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights

REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the second quarter ended June 30, 2023, and recent operational highlights.

August 2, 2023
·
18 min read
Business

Schrödinger Reports Second Quarter 2023 Financial Results

Schrödinger, Inc., whose physics-based computational platform is transforming the way therapeutics and materials are discovered, announced financial results for the quarter ended on June 30, 2023.

August 2, 2023
·
19 min read
Biotech Beach

Equillium Announces $7.5 Million Share Repurchase Program

Equillium, Inc. announced that its Board of Directors authorized the repurchase of up to $7.5 million of shares of the Company’s common stock.

August 2, 2023
·
5 min read
Business

Molecular Templates Announces Executive Leadership Changes - August 02, 2023

Molecular Templates, Inc. announced executive management changes to implement its next phase of development.

August 2, 2023
·
6 min read
Lone Star Bio

Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference

Natera, Inc. announced that members of its leadership team will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, Aug. 9 at 4:30 pm ET | 1:30 pm PT in Boston, MA.

August 2, 2023
·
1 min read
Business

Evolent Announces Second Quarter 2023 Results

Evolent Health, Inc. announced financial results for the quarter ended June 30, 2023.

August 2, 2023
·
31 min read
Business

Envista Reports Second Quarter 2023 Earnings

Envista Holdings Corporation announced results for the second quarter 2023.

August 2, 2023
·
25 min read
Business

Myomo to Report Second Quarter Financial Results on August 9, 2023

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”) today announced that it will report financial results for the three and six months ended June 30, 2023 on August 9, 2023.

August 2, 2023
·
2 min read
Business

Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the second quarter ended June 30, 2023.

August 2, 2023
·
11 min read
Business

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2023 ended June 30, 2023, after the market closes on Tuesday, August 8, 2023, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

August 2, 2023
·
4 min read